Use of Annexin V for the identification of fetal cells in maternal circulation

In Vivo

Volumn 18, Issue 5, 2004, Pages 629-632

  Kolialexi, Aggeliki ^a   Tsangaris, George Th ^b   Antsaklis, Aristides ^a   Kitsiou Tzeli, Sofia ^a   Mavrou, Ariadni ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Annexin V; Apoptosis; Maternal peripheral blood; Non invasive prenatal diagnosis

Indexed keywords

LIPOCORTIN 5;

ADULT; ANALYTIC METHOD; APOPTOSIS; ARTICLE; BLOOD ANALYSIS; CELL ISOLATION; CELL POPULATION; CHROMOSOME ABERRATION; CLINICAL PROTOCOL; CONJUGATION; CONTROLLED STUDY; DELIVERY; DIAGNOSTIC ACCURACY; FEMALE; FETUS; FETUS CELL; FLUORESCENCE IN SITU HYBRIDIZATION; GESTATION PERIOD; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOLECULAR PROBE; MOTHER; NON INVASIVE MEASUREMENT; PRENATAL DIAGNOSIS; PUERPERIUM; QUANTITATIVE ANALYSIS; SECOND TRIMESTER PREGNANCY; SYSTEMIC CIRCULATION; THIRD TRIMESTER PREGNANCY; X CHROMOSOME; Y CHROMOSOME;

EID: 6944243890     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Alles A, Alley K, Barret JC, Buttyan R, Columbiano A, Cope FO, Copelan EA, Duke RC, Farel PB, Gershenson LE et al: Apoptosis: a general comment. FASEB J 5: 2127-2128, 1991.
2. Bursch W, Oberhammer F and Schulte-Herman R: Cell death by apoptosis and its protective role against disease. Th Pharmac Sci 13 45-251, 1992.
3. Kolialexi A, Tsangaris GTh, Antsaklis A, Tzortzatou F, Amentas C, Koratzis A and Mavrou A: Apoptosis in maternal peripheral blood during pregnancy. Fetal Diagn Ther 16: 32-37, 2001.
4. Koopman G, Reutelingperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST and Van Oers MHJ: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84: 1415-1420, 1994.
5. Martin SJ, Reutlingsperger CPM, McGahon AJ, Rader JA, van Schie RCAA, LaFace DM and Gree DR: Early redistridution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating, stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 174 (21): 5191-5200, 1995.
6. Kuypers FA, Lewis RA, Hum M, Schott MA, Discher D, Emst JD and Lubin BH: Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled Annexin V. Blood 87: 1179-1187, 1996.
7. Rickers A, Brocckstedt E, Mapara MY, Omo A, Dorken B and Bommert K: Inhibition of CPP32 blocks surface IgM-mediated apoptosis and D4-GD1 cleavage in human BL60 Burkitt lymphoma cells. Eur J Immunol 28 296-304, 1998.
8. Sekisawa A, Samura O, Zhen D, Falco V, Farina A and Bianchi DW: Apoptosis in fetal nucleated erythrocytes circulating in maternal blood. Prenat Diagn 20: 886-89, 2000.
9. Wijk IJ, Hoon AC, Jurhawan R, Tjoa ML, Griffioen S, Mulders MAM et al: Detection of apoptotic fetal cells in plasma of pregnant women. Clin Chem 46: 729-731, 2000.
10. Poon LLM, Leung TN, Lau TK and Lo YMD: Prenatal detection of fetal Down's syndrome from maternal plasma. Lancet 356: 1819-1820, 2000.
11. Bischoff FZ, Hahn S, Johnson KL, Simpson JL, Bianchi DW, Lewis DE, Weber WD, Klinger K, Elias S, Jackson LG, Evans MI, Holzgreve W and de la Cruz F: Intact fetal cells in maternal plasma: are they really there? Lancet 361: 139-140, 2003.
12. Lo YMD and Poon LLM: The ins and outs of fetal DNA in maternal plasma. Lancet 361: 193, 2003.
13. Kolialexi A, Tsangaris GTh, Mavrou A, Antsaklis A, Tzortzatou F, Touliatou V and Metaxotou C: Use of Annexin V antibody to identify apoptotic cells during pregnancy. Proc NY Acad Sci 945: 145-150, 2001.
14. Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW and Shuber AP: PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 61: 822-829, 1997.
15. Krabchi K, Gross-Louis F, Yun J, Bronsard M, Massé J, Forest JC and Drouin R: Quantification of all fetal nucleated cells in maternal blood between 18th and 22nd weeks of pregnancy using molecular cytogenetic techniques. Clin Genet 60: 145-150, 2001.
16. Lo YMD, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PMK, Wainscoat JS, Johmson PJ, Chang AMZ and Hjelm NM?I: Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62: 768-775, 1998.
17. Lo YMD, Zhang J, Leung TN, Lau TK, Chang AMZ and Hjelm M: Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 64 218-24, 1999.
18. Hamada H, Arimani T, Hamaguchi H and Kubo T: Fetal nucleated cells in maternal peripheral blood after delivery. Am J Obstet Gynecol 170: 1188-1193, 1994.
19. Thomas MR, Tutchek B, Frost A, Robeck CH, Yasdani N, Craft I and Williamson R: The time of appearance and disappearence, of fetal DNA from maternal circulation. Prenat Diagn 15: 641-646, 1995.
20. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S and DeMaria MA: Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci 93: 705-708, 1996.
21. Coles HSR, Burne IF and Raft MC: Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118: 777-784, 1993.
22. Mountz JD, Wu J, Cheng J and Zhou T: Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum 37: 1415-1420, 1994.
23. Bianchi DW: Fetomaternal cell trafficking: a new cause of disease. Am J Med Genet 91: 22-28, 2000.
24. Bianchi DW: Fetal cells in the mother: from genetic diagnosis to diseases associated with fetal cell microchimerism. Eur J Obstet Gynecol Reprod Biol 92: 103-108, 2000.